Will Neuland Laboratories recover after a 7% stock drop and plummeting profits?
Neuland Laboratories' shares plunged, extending losses due to investor concerns over a 59% drop in Q4 profit, despite strong guidance. Increased operating costs and reduced sales volumes triggered the decline. While the company anticipates better ...
By ET Bureau |
ETMarkets.com
The stock, which slumped as much as 11% during the session, closed at Rs 11,040. Last week, Neuland shares fell nearly 13%.
MUMBAI: Neuland Laboratories, one of the Dalal Street favourites in the recent bull run, tumbled almost 7% on Friday, extending losses to the third straight session, as the company’s strong guidance failed to douse investor concerns over the 59% drop in its profit after tax in the fourth quarter.
“The increase in operating costs and reduced sales volumes led to Neuland shares falling today,” said Prathamesh Masdekar, research analyst, Stoxbox. “ The concern about operating costs has been ongoing since the last two quarters.” Masdekar said that while the company guided for better growth in FY26, the company’s peers have reported better results and promising guidance as well.
The stock, which slumped as much as 11% during the session, closed at Rs 11,040. Last week, Neuland shares fell nearly 13%.
“The increase in operating costs and reduced sales volumes led to Neuland shares falling today,” said Prathamesh Masdekar, research analyst, Stoxbox. “ The concern about operating costs has been ongoing since the last two quarters.” Masdekar said that while the company guided for better growth in FY26, the company’s peers have reported better results and promising guidance as well.
The stock, which slumped as much as 11% during the session, closed at Rs 11,040. Last week, Neuland shares fell nearly 13%.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
